Skye Bioscience (SKYE) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts SKYE Hot Sheet
Join SI Premium – FREE
Skye Bioscience (NASDAQ: SKYE) reported Q2 EPS of ($0.20), $0.01 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Skye Bioscience (SKYE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo on Neurocrine Bio. (NBIX): 'Defending NBIX, We Would Be Buyers Here'
- ExxonMobil Q2 profit falls short of forecasts, shares slide
- Bank of the James (BOTJ) Tops Q2 EPS by 71c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
